| 2018-09-26 | Ehlers Michael D | EVP, Research and Development | Sell | 1,000 | $350.00 | $350,000.00 | -18.9% | → |
| 2018-04-25 | DENNER ALEXANDER J | Director | Buy | 48,000 | $269.91 | $12,955,680.00 | +11.6% | → |
| 2018-02-27 | Sandrock Alfred | EVP, Chief Medical Officer | Sell | 259 | $290.83 | $75,324.97 | -3.8% | → |
| 2018-02-23 | Sandrock Alfred | EVP, Chief Medical Officer | Sale+OE | 908 | $293.44 | $266,443.52 | -12.2% | → |
| 2018-02-20 | Sandrock Alfred | EVP, Chief Medical Officer | Sell | 743 | $292.00 | $216,956.00 | -10.2% | → |
| 2018-02-15 | Sandrock Alfred | EVP, Chief Medical Officer | Sell | 1,294 | $298.85 | $386,711.90 | -15.1% | → |
| 2018-01-09 | PANGIA ROBERT W | Director | Sale+OE | 5,832 | $329.65 | $1,922,518.80 | -24.8% | → |
| 2017-12-29 | Vounatsos Michel | Chief Executive Officer | Buy | 780 | $320.55 | $250,029.00 | +19.0% | → |
| 2017-11-29 | DENNER ALEXANDER J | Director | Buy | 30,000 | $317.36 | $9,520,800.00 | +3.8% | → |
| 2017-07-25 | ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Sell | 4,974 | $290.01 | $1,442,509.74 | -18.3% | → |
| 2017-07-19 | ALEXANDER SUSAN H | EVP Chief Legal Corp Svc & Sec | Sell | 7,758 | $285.00 | $2,211,030.00 | -22.2% | → |
| 2017-06-09 | Posner Brian S | Director | Sell | 1,084 | $256.31 | $277,840.04 | -14.6% | → |
| 2017-05-01 | Vounatsos Michel | Chief Executive Officer | Buy | 1,402 | $271.35 | $380,432.70 | +91.9% | → |
| 2017-04-27 | DENNER ALEXANDER J | Director | Buy | 73,858 | $278.50 | $20,569,475.84 | +11.6% | → |
| 2017-04-25 | Clancy Paul J | Executive VP and CFO | Sell | 9,892 | $290.00 | $2,868,680.00 | -47.8% | → |
| 2017-04-03 | Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Sell | 1,981 | $274.08 | $542,952.48 | -21.9% | → |
| 2017-03-13 | Clancy Paul J | Executive VP and CFO | Sell | 9,891 | $291.55 | $2,883,721.05 | -32.3% | → |
| 2017-03-01 | Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Sell | 973 | $290.07 | $282,238.11 | -9.7% | → |
| 2017-02-27 | Vounatsos Michel | Chief Executive Officer | Buy | 1,333 | $285.39 | $380,424.87 | +1,321% | → |
| 2017-01-09 | PANGIA ROBERT W | Director | Sale+OE | 5,450 | $295.39 | $1,609,875.50 | -24.7% | → |
| 2016-12-01 | Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Sell | 48 | $296.53 | $14,233.44 | -0.6% | → |
| 2016-10-04 | Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Sell | 262 | $311.94 | $81,728.28 | -3.3% | → |
| 2016-10-03 | Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Sale+OE | 380 | $313.00 | $118,940.00 | -4.6% | → |
| 2016-09-22 | DORSA CAROLINE | Director | Sale+OE | 27,570 | $314.00 | $8,656,980.00 | -61.7% | → |
| 2016-07-21 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 157 | $280.00 | $43,960.00 | -0.3% | → |
| 2016-06-06 | Koppel Adam | EVP, Strategy and Bus. Dev. | Sell | 555 | $290.00 | $160,950.00 | -18.8% | → |
| 2016-06-03 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 842 | $290.00 | $244,180.00 | -1.5% | → |
| 2016-06-01 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 3,855 | $289.74 | $1,116,961.39 | -3.3% | → |
| 2016-05-25 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 157 | $280.00 | $43,960.00 | -0.3% | → |
| 2016-05-02 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 487 | $274.74 | $133,798.38 | -0.8% | → |
| 2016-04-06 | Koppel Adam | EVP, Strategy and Bus. Dev. | Sell | 102 | $275.00 | $28,050.00 | -5.2% | → |
| 2016-04-06 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 157 | $280.00 | $43,960.00 | -0.3% | → |
| 2016-04-01 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 487 | $258.83 | $126,050.21 | -0.8% | → |
| 2016-03-01 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 487 | $261.37 | $127,287.19 | -0.8% | → |
| 2016-02-25 | Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Sell | 183 | $261.90 | $47,927.70 | -2.2% | → |
| 2016-02-25 | Karaboutis Adriana | EVP, Tech, Bus. Sol & Corp Aff | Sell | 84 | $261.90 | $21,999.60 | -1.0% | → |
| 2016-02-17 | SCANGOS GEORGE A | Chief Executive Officer | Sell | 487 | $256.16 | $124,749.92 | -0.8% | → |
| 2016-02-17 | Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Sell | 722 | $256.16 | $184,947.52 | -8.3% | → |
| 2016-02-09 | Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Sale+OE | 852 | $246.54 | $210,052.08 | -9.9% | → |
| 2015-12-04 | Sandrock Alfred | EVP CMO Neuro & Neurodegenerat | Sell | 441 | $277.00 | $122,157.00 | -5.4% | → |
| 2015-12-02 | Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Sell | 48 | $289.14 | $13,878.72 | -0.6% | → |
| 2015-10-23 | DENNER ALEXANDER J | Director | Buy | 310,000 | $277.47 | $86,015,000.00 | +147.6% | → |
| 2015-10-05 | Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Sell | 269 | $291.43 | $78,394.67 | -3.2% | → |
| 2015-10-02 | Karaboutis Adriana | EVP, Tech. and Bus. Solutions | Sale+OE | 417 | $283.38 | $118,169.46 | -4.7% | → |
| 2015-07-27 | PAPADOPOULOS STELIOS | Director | Buy | 10,000 | $304.88 | $3,048,775.00 | New | → |